**Core Concept:** Myocardial infarction (MI), also known as a heart attack, occurs when there is a sudden blockage in one of the coronary arteries supplying blood to the heart muscle. This blockage prevents oxygen-rich blood from reaching the heart muscle cells, leading to damage or death of these cells. The most common cause of MI is atherosclerosis, where fatty deposits (plaques) build up within the arteries, reducing blood flow and potentially leading to a thrombosis.

**Why the Correct Answer is Right:** Statins are a class of drugs that inhibit the enzyme HMG-CoA reductase, which is involved in cholesterol synthesis. By reducing cholesterol production, statins help lower low-density lipoprotein (LDL) cholesterol levels. Lowering LDL cholesterol reduces the risk of plaque formation and stabilizes existing plaques, thereby preventing atherosclerosis progression and reducing the risk of MI.

**Why Each Wrong Option is Incorrect:**

A. Nitroglycerin: This drug is used for angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle. While nitroglycerin does improve blood flow to the heart in the short term, it does not address the underlying atherosclerosis and is not a primary preventive measure for MI.

B. Aspirin: Aspirin is an antiplatelet agent that prevents platelet aggregation, thereby reducing the risk of arterial thrombosis and stroke. However, its use is usually indicated in patients with established atherosclerosis or those who have already experienced a thrombotic event, not for primary prevention of MI.

C. Beta-blockers: Beta-blockers are used to reduce heart rate, blood pressure, and myocardial oxygen demand, thereby decreasing the workload on the heart. They may help reduce the risk of MI in patients with established coronary artery disease but are not a primary preventive measure for MI in the general population.

D. Angiotensin-converting enzyme inhibitors (ACE inhibitors): ACE inhibitors are used to lower blood pressure and improve cardiac output, thereby reducing the risk of MI in patients with established coronary artery disease. They are not a primary preventive measure for MI in the general population.

**Clinical Pearl:** The appropriate drug for preventing MI in the general population is a statin, as it addresses the primary cause (atherosclerosis) and helps reduce the risk of plaque formation, thereby preventing MI. Statins are also beneficial in patients with established coronary artery disease as they reduce the risk of further events like myocardial infarction and stroke.